Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women

J Clin Invest. 1996 Jan 1;97(1):14-21. doi: 10.1172/JCI118382.

Abstract

Although bone loss around the time of menopause is driven by estrogen deficiency, the roles of estrogens and androgens in the preservation of skeletal mass at other stages of life are less well understood. To address this issue we studied 231 women between the ages of 32 and 77 with multiple measurements of sex steroids and bone mass over a period of 2-8 yr. In all women bone mass was negatively associated with concentrations of sex-hormone binding globulin, and positively associated with weight. Bone loss occurred from all skeletal sites in peri- and postmenopausal women, but premenopausal women lost bone only from the hip (-0.3%/yr) and had positive rates of change in the radius and spine. Bone loss was significantly associated with lower androgen concentrations in premenopausal women, and with lower estrogens and androgens in peri- and postmenopausal women. Sex steroids are important for the maintenance of skeletal integrity before menopause, and for as long as 20-25 yr afterwards.

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Body Height
  • Body Weight
  • Bone Density / physiology*
  • Female
  • Gonadal Steroid Hormones / blood
  • Gonadal Steroid Hormones / physiology*
  • Humans
  • Middle Aged
  • Osteoporosis, Postmenopausal / physiopathology*
  • Premenopause / physiology*
  • Prospective Studies
  • Regression Analysis
  • Sex Hormone-Binding Globulin / analysis
  • Sex Hormone-Binding Globulin / physiology

Substances

  • Gonadal Steroid Hormones
  • Sex Hormone-Binding Globulin